Drugs Information:
Raltegravir
Basic Information
|
|
||
| ID | DDInter1563 | |
| Drug Type | small molecule | |
| Molecular Formula | C20H21FN6O5 | |
| Molecular Weight | 444.416 | |
| CAS Number | 518048-05-0 | |
| Description | Raltegravir is an antiretroviral drug produced by Merck & Co., used to treat HIV infection. It received approval by the U.S. Food and Drug Administration (FDA) on 12 October 2007, the first of a new class of HIV drugs, the integrase inhibitors, to receive such approval. | |
| ATC Classification | J05AR16 J05AJ01 | |
| IUPAC Name | N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-{2-[(5-methyl-1,3,4-oxadiazol-2-yl)formamido]propan-2-yl}-6-oxo-1,6-dihydropyrimidine-4-carboxamide | |
| InChI | CZFFBEXEKNGXKS-UHFFFAOYSA-N | |
| Canonical SMILES | CN1C(=O)C(O)=C(N=C1C(C)(C)NC(=O)C1=NN=C(C)O1)C(=O)NCC1=CC=C(F)C=C1 | |
| Useful Links | DrugBank ChEBI PubChem Substance KEGG Drug ChemSpider BindingDB Wikipedia ChEMBL ZINC | |
Interactions with
Raltegravir
Filter:
| Severity level | ID | Name | Mechanism | Detail |
|---|
Interactions with diseases
Filter:
| Severity level | Disease name | Text | References |
|---|
Interactions with foods
Filter:
| Severity level | Food name | Description | Management | Mechanism | References |
|---|
Interactions with compound preparation
| Multi-DRUG trade | Multi-DRUG | Drug type | Warning | Note |
|---|